2 terminated, 1 completed, 1 unknown. 4 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 2, Completed 1, Unknown 1 |
| Phase 2 | 4 | Terminated 2, Completed 1, Unknown 1 |
Follow Primary Immunodeficiency: new trials by email Literature Review of Primary Immunodeficiency trials Research Report on Primary Immunodeficiency
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bilateral Orthotopic Lung Transplant - Bone Marrow Transplant CD3/CD19 neg allogeneic BMT - Primary Immunodeficiency, PID | Phase 1 / Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 5 | 2017-12-01 | 2025-07-22 |
| Long Term Follow-up Study for Patients Enrolled on the BP-004 Clinical Study Rimiducid, rivogenlecleucel - Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child | Phase 1 / Phase 2 | Terminated | Bellicum Pharmaceuticals | 187 | 2017-01-01 | 2023-09-26 |
| ASIS for GAMMAGARD in Primary Immunodeficiency Gadolinium For abdomen, Gadolinium For lower back, Efficacy of Gammagard subcutaneously at Week 12 - Primary Immunodeficiency | Phase 1 / Phase 2 | Unknown | ASIS Corporation | 60 | 2016-01-01 | 2015-06-24 |
| Safety Study of Gene Modified Donor T-cells Following TCRαβ+ Depleted Stem Cell Transplant BPX-501 T cells, Rimiducid - Acute Lymphoblastic Leukemia, Leukemia, Acute Myeloid (AML), Child | Phase 1 / Phase 2 | Terminated | Bellicum Pharmaceuticals | 187 | 2014-04-01 | 2023-09-29 |
Primary Immunodeficiency Diseases (4) · Anemia (2) · Anemia, Aplastic (2) · Anemia, Diamond-Blackfan (2) · Anemia, Sickle Cell (2) · Cytopenia (2) · Fanconi Anemia (2) · Hematologic Neoplasms (2) · Hemoglobinopathies (2) · Leukemia (2) · Leukemia, Myeloid, Acute (2) · Lymphoma, Non-Hodgkin (2) · Myelodysplastic Syndromes (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Thalassemia (2)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (4) · Genetic Diseases, Inborn (4) · Immune System Diseases (4) · Immunologic Deficiency Syndromes (4) · Anemia, Hemolytic (2) · Anemia, Hemolytic, Congenital (2) · Anemia, Hypoplastic, Congenital (2) · Bone Marrow Diseases (2) · Bone Marrow Failure Disorders (2) · Congenital Bone Marrow Failure Syndromes (2) · DNA Repair-Deficiency Disorders (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Immunoproliferative Disorders (2) · Leukemia, Lymphoid (2)
AP 1903 reagent (2) · Gadolinium (1) · Gadolinium DTPA (1) · Immunoglobulins, Intravenous (1)
Bellicum Pharmaceuticals (2) · ASIS Corporation (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Italy (2) · United States (2) · United Kingdom (1)
Hanh Nguyen, MD (1) · Li Nguyen, MD (1) · Paul Szabolcs, MD (1) · Thanh Phung, MD (1)
U01AI125050 (1)